NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Barry Gidal
AD Scientific Index 2024
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
University of Wisconsin Madison - Madison / United States
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Barry Gidal's MOST POPULAR ARTICLES
1-)
Practice parameter update: management issues for women with epilepsy—focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality …CL Harden, KJ Meador, PB Pennell, WA Hauser, GS Gronseth, JA French, ...Neurology 73 (2), 133-141, 2009672*2009
2-)
Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy [RETIRED]: Report of the Therapeutics and Technology Assessment Subcommittee and …JA French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ...Neurology 62 (8), 1252-1260, 20046122004
3-)
Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy [RETIRED]: Report of the Therapeutics and Technology Assessment Subcommittee and …JA French, AM Kanner, J Bautista, B Abou-Khalil, T Browne, CL Harden, ...Neurology 62 (8), 1252-1260, 20046162004
4-)
Enzyme induction with antiepileptic drugs: cause for concern?MJ Brodie, S Mintzer, AM Pack, BE Gidal, CJ Vecht, D SchmidtEpilepsia 54 (1), 11-27, 20134162013
5-)
A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly …L Taylor, B Gidal, G Blakey, B Tayo, G MorrisonCNS drugs 32, 1053-1067, 20183912018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept